Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HOB Biotech GroupSHSE:688656 -2.73%83 OCF Yield % is 1.47 as of Jul. 24, 2026, which is 36% below its 10-year median of 2.30. GuruFocus rates SHSE:688656 with a GF Score™ of 83/100 and a GF Value™ of ¥89.36 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 850 Medical Devices & Instruments companies, HOB Biotech Group ranks worse than 51.53% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for HOB Biotech Group's OCF Yield % or its related term are showing as below:
SHSE:688656'
s OCF Yield % Range Over the Past 10 Years
Min: 0.63 Med: 2.3 Max: 8.52
Current: 1.47
During the past 10 years, the highest OCF Yield % of HOB Biotech Group was 8.52%. The lowest was 0.63%. And the median was 2.30%.
SHSE:688656's OCF Yield % is ranked worse than 51.53% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 1.745
vs SHSE:688656: 1.47
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
HOB Biotech Group OCF Yield % Related Terms
HOB Biotech Group OCF Yield % Historical Data
* Premium members only.
The historical data trend for HOB Biotech Group's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688656 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, HOB Biotech Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HOB Biotech Group OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's OCF Yield % distribution charts can be found below:
* The bar in red indicates where HOB Biotech Group's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HOB Biotech Group (SHSE:688656) has a OCF Yield % of 1.47 as of Jul. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HOB Biotech Group and its competitors. This is 36% below median its historical median of 2.30. Over the past decade, HOB Biotech Group's OCF Yield % has ranged from 0.63 to 8.52. According to the industry distribution chart, HOB Biotech Group ranks #438 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 51.5%.
Is HOB Biotech Group's OCF Yield % too high?
HOB Biotech Group's current OCF Yield % of 1.47 is 36% below median its 10-year median of 2.30. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 8.52. The Medical Devices & Instruments industry median OCF Yield % is 1.75. HOB Biotech Group's value of 1.47 is 15.8% below this industry median. Based on the distribution chart, HOB Biotech Group ranks #438 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, HOB Biotech Group has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HOB Biotech Group's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HOB Biotech Group ranks #438 out of 850 companies for OCF Yield %. This places HOB Biotech Group in the lower half of its industry. The industry median OCF Yield % is 1.75. HOB Biotech Group's value of 1.47 is 15.8% below this benchmark. Historically, HOB Biotech Group's own OCF Yield % has ranged from 0.63 to 8.52 over the past decade. While the company's 10-year median is 2.30 vs. the industry median of 1.75, HOB Biotech Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.75, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HOB Biotech Group's current OCF Yield % of 1.47 is 15.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HOB Biotech Group and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HOB Biotech Group's current OCF Yield % is 1.47, which is 36% below median its own 10-year median of 2.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOB Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, HOB Biotech Group (SHSE:688656) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥89.36, compared to a current price of ¥79.04 — trading 11.5% below its estimated fair value. The current OCF Yield % is 1.47, which is 36% below median its 10-year median of 2.30 and 15.8% below the Medical Devices & Instruments industry median of 1.75. HOB Biotech Group's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For HOB Biotech Group (SHSE:688656), the current OCF Yield % is 1.47 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HOB Biotech Group (SHSE:688656) Overvalued in 2026?
Based on GuruFocus' analysis, HOB Biotech Group stock appears to be undervalued.
The current stock price of ¥79.04 is trading 11.5% below its estimated GF Value™ of ¥89.36.
GuruFocus considers HOB Biotech Group to be Modestly Undervalued.
Key valuation signals for SHSE:688656:
OCF Yield %: 1.47 (36% below median its 10-year median of 2.30)
GF Value™: ¥89.36 vs. price of ¥79.04 (11.5% below fair value)
Industry Position: 15.8% below the Medical Devices & Instruments median (#438 of 850)
No single metric tells the full story. See the SHSE:688656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
83GF Score
Get the complete analysis for SHSE:688656
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688656 has been successfully added to your 
